Revcovi
key details
| Status | complete |
|---|---|
| Region | Northern Ireland |
| Procedure | direct |
| OCID | ocds-h6vhtk-0592c8 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| CHIESI LIMITED | £3,996,000 | 2 Sept 2025 | active |
description
Procurement of Revcovi, an approved enzyme replacement therapy (ERT) indicated for the treatment of adenosine deaminase severe combined immune deficiency.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 3 Sept 2025 | Transparency notice (UK5) | Procurement Act 2023 | 053381-2025 |
| 3 Sept 2025 | Contract award (UK6) | Procurement Act 2023 | 053401-2025 |
| 15 Sept 2025 | Contract details (UK7) | Procurement Act 2023 | 056483-2025 |
more from Southern Health and Social Care Trust
- POCT Urinalysis and Urine Pregnancy testing · 23 Jun 2026
- Resuscitation Council Course Manuals and Registration Fee · £115,115 · 28 May 2026
- Enhertu solution for infusion · 28 May 2026
- Evinacinumab · 28 May 2026
- BARICITINIB TABLETS · 13 May 2026
- REMDESIVIR INFUSION · 13 May 2026
- Biktarvy · 13 May 2026
- Wheelchair Accessible Coach Transport Services for Southern Health and Social Care Trust · £8,099,773 · 5 Mar 2026
all contracts from this buyer →
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.